Ausra Lukosiute-Urboniene
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ausra Lukosiute-Urboniene has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Vidmantas Barauskas
Lithuanian University of Health Sciences, Department of Paediatric Surgery, Kaunas, Lithuania
3 shared publicationsAntanas Gulbinas
Institute for Digestive System Research, Lithuanian University of Health Sciences, Kaunas, Lithuania
2 shared publicationsGiedre Silkuniene
Institute for Digestive System Research, Lithuanian University of Health Sciences, Kaunas, Lithuania
2 shared publications- Inga Dekeryte
Pediatric Surgery Department, Lithuanian University of Health Sciences, Eivenių Str. 2, LT-50161 Kaunas, Lithuania
2 shared publications - Zilvinas Dambrauskas
Department of Surgery, Medical Academy, Faculty of Medicine, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania
2 shared publications Albertas Dauksa
Institute for Digestive System Research, Lithuanian University of Health Sciences, Kaunas, Lithuania
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by Vilnius University Press in Lietuvos chirurgija
- Vol. 24 (4) , 298-304
Solid Pseudopapillary Carcinoma of the Pancreas in a Child: Surgical Treatment and Postoperative Complications ‒ A Case Report
Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare pancreatic neoplasm with low malignant potential, most commonly occurring in young patients. Although this condition is more frequently diagnosed in adults, it accounts for approximately 8–12% of all pancreatic tumors in children. The diagnosis of SPN is challenging due to its often asymptomatic nature, with tumors typically remaining undetected until they reach a considerable size of 5–7 cm. Furthermore, some patients may present with nonspecific symptoms, which can complicate the diagnosis. The treatment of choice is formal pancreatic resection, during which the tumor is radically removed. Although the long-term prognosis for SPN is generally favorable, postoperative complications such as pancreatic fistulas are common. Treatment of these complications may require antibiotic therapy and drainage of peripancreatic fluid collections. This article presents a clinical case in which a 15-year-old girl was incidentally diagnosed with a solid pseudopapillary carcinoma located in the tail of the pancreas, and underwent formal pancreatic resection. We discussed the importance of close postoperative monitoring and the potential causes of postoperative complications.
- 1 December 2025
- Published by Vilnius University Press in Lietuvos chirurgija
- Vol. 24 (4) , 298-304
Open AccessSolid Pseudopapillary Carcinoma of the Pancreas in a Child: Surgical Treatment and Postoperative Complications ‒ A Case Report
Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare pancreatic neoplasm with low malignant potential, most commonly occurring in young patients. Although this condition is more frequently diagnosed in adults, it accounts for approximately 8–12% of all pancreatic tumors in children. The diagnosis of SPN is challenging due to its often asymptomatic nature, with tumors typically remaining undetected until they reach a considerable size of 5–7 cm. Furthermore, some patients may present with nonspecific symptoms, which can complicate the diagnosis. The treatment of choice is formal pancreatic resection, during which the tumor is radically removed. Although the long-term prognosis for SPN is generally favorable, postoperative complications such as pancreatic fistulas are common. Treatment of these complications may require antibiotic therapy and drainage of peripancreatic fluid collections. This article presents a clinical case in which a 15-year-old girl was incidentally diagnosed with a solid pseudopapillary carcinoma located in the tail of the pancreas, and underwent formal pancreatic resection. We discussed the importance of close postoperative monitoring and the potential causes of postoperative complications.
- Open Access
Does Multisystem Inflammatory Syndrome Only Mimic Acute Appendicitis in Children or Can It Coexist: When Should We Suspect MIS-C?
Background and Objectives: Acute abdominal pain in children has been noticed to be a primary reason to seek medical attention in multisystem inflammatory disorder (MIS-C), which can prevail separately or together with acute appendicitis. Our aim was to distinguish regular appendicitis cases from MIS-C and to suggest the best clinical and laboratory criteria for it. Materials and methods: Cases of patients, admitted to the Pediatric Surgery Department over a six-month period in 2021, were retrospectively analyzed. Confirmed MIS-C or acute appendicitis cases were selected. MIS-C cases were either separate/with no found inflammation in the appendix or together with acute appendicitis. Acute appendicitis cases were either regular cases or with a positive COVID-19 test. Four groups were formed and compared: A-acute appendicitis, B-MIS-C with acute appendicitis, C-MIS-C only and D-acute appendicitis with COVID-19. Results: A total of 76 cases were overall analyzed: A-36, B-6, C-29 and D-5. The most significant differences were found in duration of disease A—1.4 days, B—4.5 days, C—4 days, D—4 days (p < 0.0001), C reactive protein (CRP) values A-19.3 mg/L B-112.5 m/L, C-143.8 mg/L and D-141 mg/L (p < 0.0001), presence of febrile fever A-13.9%, B-66.7%, C-96.6% and D-40% (p < 0.0001) and other system involvement: A 0%, B 100%, C 100% and D 20%. A combination of these factors was entered into a ROC curve and was found to have a possibility to predict MIS-C in our analyzed cases (with or without acute appendicitis) with an AUC = 0.983, p < 0.0001, sensitivity of 94.3% and specificity of 92.7% when at least three criteria were met. Conclusions: MIS-C could be suspected even when clinical data and performed tests suggest acute appendicitis especially when at least three out of four signs are present: CRP > 55.8 mg, symptoms last 3 days or longer, febrile fever is present, and any kind of other system involvement is noticed, especially with a known prior recent COVID-19 contact, infection or a positive COVID-19 antibody IgG test.
Open AccessDoes Multisystem Inflammatory Syndrome Only Mimic Acute Appendicitis in Children or Can It Coexist: When Should We Suspect MIS-C?
Background and Objectives: Acute abdominal pain in children has been noticed to be a primary reason to seek medical attention in multisystem inflammatory disorder (MIS-C), which can prevail separately or together with acute appendicitis. Our aim was to distinguish regular appendicitis cases from MIS-C and to suggest the best clinical and laboratory criteria for it. Materials and methods: Cases of patients, admitted to the Pediatric Surgery Department over a six-month period in 2021, were retrospectively analyzed. Confirmed MIS-C or acute appendicitis cases were selected. MIS-C cases were either separate/with no found inflammation in the appendix or together with acute appendicitis. Acute appendicitis cases were either regular cases or with a positive COVID-19 test. Four groups were formed and compared: A-acute appendicitis, B-MIS-C with acute appendicitis, C-MIS-C only and D-acute appendicitis with COVID-19. Results: A total of 76 cases were overall analyzed: A-36, B-6, C-29 and D-5. The most significant differences were found in duration of disease A—1.4 days, B—4.5 days, C—4 days, D—4 days (p < 0.0001), C reactive protein (CRP) values A-19.3 mg/L B-112.5 m/L, C-143.8 mg/L and D-141 mg/L (p < 0.0001), presence of febrile fever A-13.9%, B-66.7%, C-96.6% and D-40% (p < 0.0001) and other system involvement: A 0%, B 100%, C 100% and D 20%. A combination of these factors was entered into a ROC curve and was found to have a possibility to predict MIS-C in our analyzed cases (with or without acute appendicitis) with an AUC = 0.983, p < 0.0001, sensitivity of 94.3% and specificity of 92.7% when at least three criteria were met. Conclusions: MIS-C could be suspected even when clinical data and performed tests suggest acute appendicitis especially when at least three out of four signs are present: CRP > 55.8 mg, symptoms last 3 days or longer, febrile fever is present, and any kind of other system involvement is noticed, especially with a known prior recent COVID-19 contact, infection or a positive COVID-19 antibody IgG test.
- Open Access
- 1 March 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, 130-132
Challenging diagnosis of abdominal tuberculosis in children: case report
- 1 March 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, 130-132
Open AccessChallenging diagnosis of abdominal tuberculosis in children: case report
- 3 July 2020
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 40 (7) , 3765-3779
Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer
Background/Aim: Apoptotic peptidase activating factor 1 (APAF-1) is essential regulator of apoptosis and inactivation by DNA methylation is common event in numerous cancer types. We investigated the regulation of APAF-1 through DNA methylation in pancreatic cancer. Materials and Methods: Datasets from 44 patients after pancreatoduodenectomy and the pancreatic adenocarcinoma (PDAC) cell lines Capan-2 and MIA PaCa-2 treated with decitabine were analyzed by RT-PCR, immunoblotting, methylation-specific PCR analysis, apoptosis and viability assays to identify effects of APAF-1 regulation. Results: APAF-1 mRNA and protein levels were significantly down-regulated, and APAF-1 methylation status was associated with perineural invasion in PDAC. Decitabine inhibited cell viability and increased apoptosis rates, however failed to restore APAF-1 mRNA and protein levels in cells. Conclusion: APAF-1 gene hypermethylation may contribute to the progression of PDAC through perineural invasion. Decitabine could sensitize pancreatic cancer cells to apoptosis and growth retardation, however, not directly through the APAF-1 demethylation process.
- 3 July 2020
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 40 (7) , 3765-3779
Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer
Background/Aim: Apoptotic peptidase activating factor 1 (APAF-1) is essential regulator of apoptosis and inactivation by DNA methylation is common event in numerous cancer types. We investigated the regulation of APAF-1 through DNA methylation in pancreatic cancer. Materials and Methods: Datasets from 44 patients after pancreatoduodenectomy and the pancreatic adenocarcinoma (PDAC) cell lines Capan-2 and MIA PaCa-2 treated with decitabine were analyzed by RT-PCR, immunoblotting, methylation-specific PCR analysis, apoptosis and viability assays to identify effects of APAF-1 regulation. Results: APAF-1 mRNA and protein levels were significantly down-regulated, and APAF-1 methylation status was associated with perineural invasion in PDAC. Decitabine inhibited cell viability and increased apoptosis rates, however failed to restore APAF-1 mRNA and protein levels in cells. Conclusion: APAF-1 gene hypermethylation may contribute to the progression of PDAC through perineural invasion. Decitabine could sensitize pancreatic cancer cells to apoptosis and growth retardation, however, not directly through the APAF-1 demethylation process.
- Open Access
- 14 January 2019
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 25 (2) , 205-219
Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer
To determine the association of human antigen R (HuR) and inhibitors of apoptosis proteins (IAP1, IAP2) and prognosis in pancreatic cancer. Protein and mRNA expression levels of IAP1, IAP2 and HuR in pancreatic ductal adenocarcinoma (PDAC) were compared with normal pancreatic tissue. The correlations among IAP1/IAP2 and HuR as well as their respective correlations with clinicopathological parameters were analyzed. The Kaplan-Meier method and log-rank tests were used for survival analysis. Immunoprecipitation assay was performed to demonstrate HuR binding to IAP1, IAP2 mRNA. PANC1 cells were transfected with either anti-HuR siRNA or control siRNA for 72 h and quantitative reverse transcription polymerase chain reaction (RT-PCR), western blot analysis was carried out. RT-PCR analysis revealed that HuR, IAP1, IAP2 mRNA expression were accordingly 3.3-fold, 5.5-fold and 8.4 higher in the PDAC when compared to normal pancreas (P < 0.05). Expression of IAP1 was positively strongly correlated with HuR expression (P < 0.05, r = 0.783). Western blot analysis confirmed RT-PCR results. High IAP1 expression, tumor resection status, T stage, lymph-node metastases, tumor differentiation grade, perineural and lymphatic invasion were identified as significant factors for shorter survival in PDAC patients (P < 0.05). Immunohistological analysis showed that HuR was mainly expressed in the ductal cancer cell’s nucleus and less so in cytoplasm. RNA immunoprecipitation analysis confirmed IAP1 and IAP2 post-transcriptional regulation by HuR protein. Following siHuR transfection, IAP1 mRNA and protein levels were decreased, however IAP2 expression levels were increased. HuR mediated overexpression of IAP1 significantly correlates with poor outcomes and early progression of pancreatic cancer. Further studies are needed to assess the underlying mechanisms.
- 14 January 2019
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 25 (2) , 205-219
Open AccessHuman antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer
To determine the association of human antigen R (HuR) and inhibitors of apoptosis proteins (IAP1, IAP2) and prognosis in pancreatic cancer. Protein and mRNA expression levels of IAP1, IAP2 and HuR in pancreatic ductal adenocarcinoma (PDAC) were compared with normal pancreatic tissue. The correlations among IAP1/IAP2 and HuR as well as their respective correlations with clinicopathological parameters were analyzed. The Kaplan-Meier method and log-rank tests were used for survival analysis. Immunoprecipitation assay was performed to demonstrate HuR binding to IAP1, IAP2 mRNA. PANC1 cells were transfected with either anti-HuR siRNA or control siRNA for 72 h and quantitative reverse transcription polymerase chain reaction (RT-PCR), western blot analysis was carried out. RT-PCR analysis revealed that HuR, IAP1, IAP2 mRNA expression were accordingly 3.3-fold, 5.5-fold and 8.4 higher in the PDAC when compared to normal pancreas (P < 0.05). Expression of IAP1 was positively strongly correlated with HuR expression (P < 0.05, r = 0.783). Western blot analysis confirmed RT-PCR results. High IAP1 expression, tumor resection status, T stage, lymph-node metastases, tumor differentiation grade, perineural and lymphatic invasion were identified as significant factors for shorter survival in PDAC patients (P < 0.05). Immunohistological analysis showed that HuR was mainly expressed in the ductal cancer cell’s nucleus and less so in cytoplasm. RNA immunoprecipitation analysis confirmed IAP1 and IAP2 post-transcriptional regulation by HuR protein. Following siHuR transfection, IAP1 mRNA and protein levels were decreased, however IAP2 expression levels were increased. HuR mediated overexpression of IAP1 significantly correlates with poor outcomes and early progression of pancreatic cancer. Further studies are needed to assess the underlying mechanisms.